Next-Generation Sequencing in Clinical Molecular Diagnostics of Cancer: Advantages and Challenges
about
Epigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progressionGood Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel Tests.Validation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid Tumors.Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors.The reliable assurance of detecting somatic mutations in cancer-related genes by next-generation sequencing: the results of external quality assessment in China.Versatile ion S5XL sequencer for targeted next generation sequencing of solid tumors in a clinical laboratoryCell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL.Ovarian metastasis from lung adenocarcinoma with ALK-positive rearrangement detected by next generation sequencing: A case report and literatures review.Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies.Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice.Phylogeographic analysis of hemorrhagic fever with renal syndrome patients using multiplex PCR-based next generation sequencing.The next generation of cancer management.Next-Generation Sequencing: The Translational Medicine Approach from "Bench to Bedside to Population".The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer.EGFR with TKI-sensitive mutations in exon 19 is highly expressed and frequently detected in Chinese patients with lung squamous carcinoma.Detection of somatic variants and EGFR mutations in cell-free DNA from non-small cell lung cancer patients by ultra-deep sequencing using the ion ampliseq cancer hotspot panel and droplet digital polymerase chain reaction.Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature.NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial.Innovative methodology for the identification of soluble biomarkers in fresh tissues.A Next-Generation Sequencing Primer-How Does It Work and What Can It Do?The utilization of next-generation sequencing to detect somatic mutations and predict clinical prognosis of Chinese non-small cell lung cancer patients.MET amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancer.Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients
P2860
Q33591453-A31CA1FB-69B4-44DA-AF91-2BD169325BD7Q33729699-5454DDFC-4098-4124-B3FB-8BDC351A83FCQ35996102-A177B300-E795-4F41-B347-91AB66AB6CAFQ36270828-81D20A51-FB98-40BD-85A9-361BD48C853BQ37629053-B20E7571-B5F2-40A6-B532-F3FB12ED24CAQ38646681-0CC079E1-ABC7-48EA-9F89-7C358F64A702Q38824891-E6D59D18-D063-4EE5-A0B7-CBBC5F3144C8Q38966415-50D8798B-DEE2-44E6-9B4C-65A015AE6271Q39210850-2AB1DF69-0220-4476-8991-710A9A56DC2BQ39453553-4A682C4C-8E38-405D-8564-81419861693EQ39473116-E36407F2-5302-4844-A8AC-0C897AA3AEB3Q40084048-D4542F4C-6BDD-4DE8-9A1C-DF8742BC04E2Q40104373-0B8137A0-E4F5-497B-B7CC-FFA40E311C08Q40784008-872355D0-374E-4264-B9A0-782067C1CE09Q41747887-D64DACA1-96BF-4E24-9BCC-7335785CB266Q42643276-8C8D02DC-CBF0-4B9B-AD9A-20EC3CECEB64Q42731684-6065AAC9-E825-474B-B711-D382BED2C2BCQ47109269-D585BFE2-3917-491B-B350-F941EBE020CEQ48110433-B135FB93-FE0C-40D5-AEB3-053E8C17E2ADQ48842485-6EA0A4CD-D8A5-472A-AC4C-DC1A62613B10Q51734150-644FE519-60BC-432E-8303-82F995A35993Q54996932-13841506-1779-4CAF-BA08-5800B6E4AF56Q55314072-67445C15-02A4-443E-BB97-4E58D979D6D7Q55347158-BF93DEE2-602F-43A1-B7DF-5443838C12DCQ57174616-99566DB4-ED2C-4F90-B620-54A79334A5FB
P2860
Next-Generation Sequencing in Clinical Molecular Diagnostics of Cancer: Advantages and Challenges
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Next-Generation Sequencing in ...... cer: Advantages and Challenges
@ast
Next-Generation Sequencing in ...... cer: Advantages and Challenges
@en
Next-Generation Sequencing in ...... cer: Advantages and Challenges
@nl
type
label
Next-Generation Sequencing in ...... cer: Advantages and Challenges
@ast
Next-Generation Sequencing in ...... cer: Advantages and Challenges
@en
Next-Generation Sequencing in ...... cer: Advantages and Challenges
@nl
prefLabel
Next-Generation Sequencing in ...... cer: Advantages and Challenges
@ast
Next-Generation Sequencing in ...... cer: Advantages and Challenges
@en
Next-Generation Sequencing in ...... cer: Advantages and Challenges
@nl
P2093
P2860
P3181
P356
P1433
P1476
Next-Generation Sequencing in ...... cer: Advantages and Challenges
@en
P2093
R Rajesh Singh
Rajyalakshmi Luthra
Sinchita Roy-Chowdhuri
P2860
P304
P3181
P356
10.3390/CANCERS7040874
P407
P577
2015-01-01T00:00:00Z